HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raphaele Siou-Mermet Selected Research

Loteprednol Etabonate (Alrex)

2/2014Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%.
2/2013Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery.
1/2012Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raphaele Siou-Mermet Research Topics

Disease

3Inflammation (Inflammations)
02/2014 - 01/2012
2Cataract (Cataracts)
02/2013 - 01/2012
1Pain (Aches)
02/2013
1Photophobia (Light Sensitivity)
02/2013
1Postoperative Pain
01/2012
1Dry Eye Syndromes (Dry Eye Syndrome)
11/2011

Drug/Important Bio-Agent (IBA)

3Loteprednol Etabonate (Alrex)FDA Link
02/2014 - 01/2012
1Pharmaceutical PreparationsIBA
02/2014
1EstersIBA
02/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2014
1Ointments (Pastes)IBA
01/2012
1SuspensionsIBA
01/2012
1HLA-DR Antigens (HLA-DR)IBA
11/2011
1AntigensIBA
11/2011
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
11/2011